NKTR inhibitors refer to a class of chemical compounds designed to modulate the activity of NKTR, a key player in various biological signaling pathways. These inhibitors typically function by binding to NKTR proteins, affecting their structural conformation or enzymatic activity. This modulation can interfere with the biochemical signaling cascades initiated by NKTR, which are often involved in various regulatory functions within cells, including signal transduction, gene expression, and metabolic processes. The structure of NKTR inhibitors often includes specific molecular features that allow for high affinity and selectivity to NKTR proteins, enabling precise modulation of their activity without affecting other cellular components. This specificity is critical for studying the role of NKTR in cellular processes.
From a chemical standpoint, NKTR inhibitors can vary in their composition, but they often share common structural motifs that facilitate interaction with NKTR's active or binding sites. These motifs can include aromatic rings, hydrogen bonding groups, and hydrophobic regions, which help in stabilizing the inhibitor-protein complex. Their design is informed by detailed structural knowledge of NKTR, including its protein domains and interaction networks. Modifications in the chemical structure of NKTR inhibitors, such as altering side chains or functional groups, can optimize their binding efficiency or stability, further refining their inhibitory action. These compounds are of particular interest in biochemical research for studying how NKTR proteins regulate cellular activities and how their inhibition can lead to alterations in cellular signaling pathways.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3 kinase inhibitor affecting various cellular pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3 kinase inhibitor affecting multiple intracellular processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Rho-associated protein kinase (ROCK) inhibitor potentially impacting cytoskeletal arrangements. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor affecting inflammatory responses and other cellular pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor which impacts cell growth and proliferation. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR tyrosine kinase inhibitor affecting cell signaling. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Broad-spectrum tyrosine kinase inhibitor impacting multiple signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor influencing apoptosis and other cellular functions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Another MEK inhibitor influencing the MAPK/ERK pathway. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK-STAT signaling pathway inhibitor. |